Acorah Software Products - Accounts Production 16.7.461 false true true false 24 March 2024 31 March 2025 31 March 2025 15590176 Mrs E O'Brien iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15590176 2024-03-23 15590176 2025-03-31 15590176 2024-03-24 2025-03-31 15590176 frs-core:CurrentFinancialInstruments 2025-03-31 15590176 frs-core:ShareCapital 2025-03-31 15590176 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 15590176 frs-bus:PrivateLimitedCompanyLtd 2024-03-24 2025-03-31 15590176 frs-bus:FilletedAccounts 2024-03-24 2025-03-31 15590176 frs-bus:SmallEntities 2024-03-24 2025-03-31 15590176 frs-bus:AuditExempt-NoAccountantsReport 2024-03-24 2025-03-31 15590176 frs-bus:SmallCompaniesRegimeForAccounts 2024-03-24 2025-03-31 15590176 frs-bus:Director1 2024-03-24 2025-03-31 15590176 frs-countries:EnglandWales 2024-03-24 2025-03-31
Registered number: 15590176
E & S Medical Services Ltd
Unaudited Financial Statements
For the Period 24 March 2024 to 31 March 2025
Strategic Partnership
E & S Medical Services Ltd
Contents
Contents
Page
Company Information 1
Statement of Financial Position 2
Notes to the Financial Statements 3—4
Page 1
E & S Medical Services Ltd
Company Information
For the Period 24 March 2024 to 31 March 2025
Company Information
Director Mrs E O'Brien
Company Number 15590176
Registered Office 5 Devereux Place
Leadenhall
Milton Keynes
England
MK6 5LQ
Accountants Strategic Partnership
Strategic Partner 1 Ltd
7 Bell Yard
London
WC2A 2JR
Page 1
Page 2
E & S Medical Services Ltd
Statement of Financial Position
As At 31 March 2025
Statement of Financial Position
Registered number: 15590176
31 March 2025
Notes £ £
CURRENT ASSETS
Cash at bank and in hand 1,250
1,250
Creditors: Amounts Falling Due Within One Year 4 (19,369 )
NET CURRENT ASSETS (LIABILITIES) (18,119 )
TOTAL ASSETS LESS CURRENT LIABILITIES (18,119 )
NET LIABILITIES (18,119 )
CAPITAL AND RESERVES
Called up share capital 5 1
Income Statement (18,120 )
SHAREHOLDERS' FUNDS (18,119)
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Income Statement.
On behalf of the board
Mrs E O'Brien
Director
9 December 2025
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
E & S Medical Services Ltd
Notes to the Financial Statements
For the Period 24 March 2024 to 31 March 2025
Notes to the Financial Statements
1. General Information
E & S Medical Services Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15590176 . The registered office is 5 Devereux Place, Leadenhall, Milton Keynes, England, MK6 5LQ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
These financial statements are prepared in accordance with the FRS 102 Section 1A Small Entities - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.
These financial statements for the period ended 31 March 2025 are the first financial statements of E & S Medical Services Ltd prepared in accordance with FRS 102 (Section 1A), The Financial Reporting Standard applicable in the UK and Republic of Ireland. The date of adoption to FRS 102 (Section 1A) was 24 March 2024.
The financial statements are prepared in UK sterling, which is the financial currency of the entity. Monetary amounts in these financial statements are rounded to the nearest UK pound.
The principle accounting policies adopted are set below.
2.2. Going Concern Disclosure
The director has considered the prospect of the business for the next twelve months and beyond and has arrived at a reasonable expectation the company will continue to meet its obligations as they fall due. The director has also pledged their financial support to assist with this if required. On this basis, the director will continue to adopt the going concern basis of accounting in preparing the financial statements.
2.3. Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
2.4. Cash and Cash Equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
2.5. Critical Accounting Judgements And Key Sources of Estimation Uncertainty
In the application of the company's accounting policies management is required to make judgements, estimates and assumptions about the carrying
value of assets and liabilities that are not readily ascertainable from other sources. The estimates and underlying assumptions are based on historical
experience and other factors that are considered to be relevant. Actual outcomes may differ from these estimates.
The estimates and underlying assumptions are reviewed on a continuing basis. Revisions to accounting estimates are recognised in the period in
which the estimates are revised.
The key areas of estimation uncertainty that have a significant effect on the amounts recognised in the financial statements are described below:
Accrued Expenditure
The company includes a provision for invoices which are yet to be received from and amounts paid in advance to suppliers. These provisions are
estimated based upon the expected values of the invoices which are issued and services received following the period end.
3. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
4. Creditors: Amounts Falling Due Within One Year
31 March 2025
£
Other taxes and social security 5,028
Accruals and deferred income 1,600
Director's loan account 12,741
19,369
Page 3
Page 4
E & S Medical Services Ltd
Notes to the Financial Statements (continued)
For the Period 24 March 2024 to 31 March 2025
5. Share Capital
31 March 2025
£
Allotted, Called up and fully paid 1
During the period, the company issued 1 Ordinary Shares, for the nominal value of £1 per share. As at 31 March 2025 there is 1 Ordinary Share in issue.
6. Related Party Transactions
As at 31 March 2025, the Directors Loan Account balance of Mrs Elizabeth O'brien is £12,741, which is a current liability, interest free and repayable on demand.
Page 4